| Financial Year |
March 31 2023 |
| Monetary Funds |
394,085,520.85 |
| Held-for-trading Financial Assets |
76,563,153.07 |
| Notes Receivable |
189,980,859.96 |
| Accounts Receivable |
239,342,529.47 |
| Advances to Suppliers |
2,704,045.62 |
| Other Receivables |
377,269.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
141,262,303.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,929,450.10 |
| Total Current Assets |
1,161,078,229.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,599,424.99 |
| Fixed Assetes |
227,464,115.74 |
| Under-construction Projects |
28,374,661.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,613,874.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,109,181.51 |
| Deferred Income Tax Assets |
6,154,944.65 |
| Other Non-Current Assets |
8,334,676.78 |
| Sub-Total of Non-Current Assets |
347,289,904.34 |
| Total Assets |
1,508,368,133.52 |
| Short-Term Loans |
97,892,383.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
183,836,160.92 |
| Accounts Payable |
143,062,718.77 |
| Accounts Received In Advance |
275,523.00 |
| Employee Compensation Payable |
14,858,010.38 |
| Taxes Payable |
4,778,276.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,275,259.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,280,172.44 |
| Other Current Liabilities |
2,048,669.38 |
| Sub-Total of Current Liabilities |
452,286,189.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,091,609.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,573,288.73 |
| Total Liabilities |
468,859,477.76 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
722,059,724.71 |
| Surplus Reserve |
26,771,809.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
207,603,706.73 |
| Minority Stockholder's Interest |
3,073,414.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,036,435,241.39 |
| Owner's Equity（Stockholder's Equity） |
1,039,508,655.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,508,368,133.52 |
